BALTIMORE, Md. (Ivanhoe Newswire) – Nearly 28 million women suffer from painful uterine fibroids, and a related condition called endometriosis. Both cause severe period pain and may lead to infertility. Now, there is new hope for those who’ve endured this excruciating pain.
Caitlin Winegrove is an elementary school teacher who one day hopes to have kids of her own.
“In teaching first grade, it’s very important that you move quickly and show up with your energy every day,” Winegrove says.
But with each menstrual period, she’s sitting down from the pain of fibroid tumors and endometriosis.
Fibroids are non-cancerous stalk-like growths inside the uterus. Endometriosis causes tissue to grow outsidethe uterus.
Mercy Medical System gynecological surgeon, Latasha Murphy, MD says, “With fibroid pain, people feel very heavy and a pressure associated with it. With endometriosis pain, typically, that’s described as a burning or sharp stabbing type of sensation.”
Dr. Murphy performed Winegrove’s minimally invasive laparoscopy revealing 10 fibroids.
“We were able to remove endometriosis from, about, four different locations in her pelvis,” Dr. Murphy informs Ivanhoe.
Post procedure, Dr. Murphy prescribed a new FDA-approved drug called Myfembree.
“It decreases the brain’s message to the ovaries to create estrogen. Estrogen stimulates endometriosis and fibroids to grow,” Dr. Murphy explains.
Winegrove says with relief, “I haven’t been experiencing, really, any cramping. I’ve had very light periods since starting it.”
Myfembree was approved by the FDA in mid 2022. In addition to treating fibroids and endometriosis, the drug also serves as an alternative to birth control pills.
Contributors to this news report include: Donna Parker, Producer; Kirk Manson, Videographer; Roque Correa, Editor.
To receive a free weekly e-mail on medical breakthroughs from Ivanhoe, sign up at: http://www.ivanhoe.com/ftk
